Vitrocell reports successful participation in the 6th World Congress on Alternatives and Animal Use in the Life Sciences in Tokyo

Approximately 1.000 scientists from all over the world met in Tokyo on 21-25 August, 2007 to exchange their views on the latest developments on alternative methods to animal tests in life sciences.

Waldkirch, (PresseBox) - The large number of participants from outside Japan showed that this topic is of great importance in the international research community.

Objectives of the conference were to:

1. Review progress made toward the 3Rs (Reduction, Refinement, Replacement) in education, research, and testing.
2. Develop a realistic understanding of the status of alternative methods to animal testing.
3. Create an understanding that in research, animal studies, together with clinical studies and in vitro methods as well as to advance science.
4. Contribute to the basic understanding of biology and diseases.
5. Encourage constructive discussions between animal protection groups and scientific communities.

Most animal experiments for evaluating the safety of cosmetics will be prohibited in the EU in 2009. For the acceptance of alternative methods by 2009, a series of alternative methods or concrete plans for validation of new methods are needed. The results of the WC6 will have a significant influence on the policies regarding alternatives to animal testing.

The past World Congresses were held in Baltimore (1993), Utrecht (1996), Bologna (1999), New Orleans (2002), Berlin (2005) followed now by Tokyo (2007). It was announced that the next congress will be held 2009 in Rome.

VITROCELL® SYSTEMS participated in the exhibition and showed it’s large product program of equipment for the in vitro analysis of airborne substances such as gases, nano particles and complex mixtures. The VITROCELL® product range helps to reduce animal testing in the field of e. g. inhalation toxicology. For this purpose human cells are cultivated in special exposure modules on membranes and then exposed at the air/liquid interface to the test substances. The customers of VITROCELL® are leading medical and environmental research institutes as well as the pharmaceutical and other industries.

is specialised in the development, manufacturing, sales and service of new, innovative cultivation and exposure techniques for in vitro studies. Production skills cover a full range from VITROCELL© cultivation and exposure systems for cells at the air/liquid interface. VITROCELL© modules are a powerful tool for the analysis of gases, environmental atmospheres, nano particles and complex mixtures (e.g. cigarette smoke and diesel exhaust). Production skills cover a full range from glass blowing to engineering components as well as the implementation of special robot solutions for lab and manufacturing automation.

Press releases you might also be interested in

Weitere Informationen zum Thema "Biotechnik":

ARM und NVIDIA entwickeln gemeinsam KI-Chips

Um die Ent­wick­lung des ei­ge­nen KI-Pro­jekts Tril­li­um vor­an­zu­t­rei­ben, hat Pro­zes­sor­ent­wick­ler ARM ei­ne Part­ner­schaft mit dem GPU-Her­s­tel­ler NVI­DIA ge­sch­los­sen. Des­sen De­ep-Lear­ning-Ar­chi­tek­tur NVD­LA wird for­tan in die Tril­li­um-Platt­form in­te­griert.


Subscribe for news

The subscribtion service of the PresseBox informs you about press information of a certain topic by your choice at a choosen time. Please enter your email address to receive the email with the press releases.

An error occurred!

Thank you! You will receive a confirmation email within a few minutes.

I want to subscribe to the gratis press mail and have read and accepted the conditions.